Shareholders Compel HeartWare To Drop Valtech Deal, Stay Focused On VADS

HeartWare International abandoned its bid to get into the valve business with the acquisition of Valtech Cardio following months of pressure from an activist shareholder to abandon the deal.

HeartWare International abandoned its bid to get into the valve business with the acquisition of Valtech Cardio following months of pressure from an activist shareholder to abandon the deal.

The ventricular-assist device company announced on Jan. 28 that it was terminating its September 2015 agreement to buy Valtech

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight